These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33236009)

  • 1. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.
    Rappazzo CG; Tse LV; Kaku CI; Wrapp D; Sakharkar M; Huang D; Deveau LM; Yockachonis TJ; Herbert AS; Battles MB; O'Brien CM; Brown ME; Geoghegan JC; Belk J; Peng L; Yang L; Scobey TD; Burton DR; Nemazee D; Dye JM; Voss JE; Gunn BM; McLellan JS; Baric RS; Gralinski LE; Walker LM
    bioRxiv; 2020 Nov; ():. PubMed ID: 33236009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
    Rappazzo CG; Tse LV; Kaku CI; Wrapp D; Sakharkar M; Huang D; Deveau LM; Yockachonis TJ; Herbert AS; Battles MB; O'Brien CM; Brown ME; Geoghegan JC; Belk J; Peng L; Yang L; Hou Y; Scobey TD; Burton DR; Nemazee D; Dye JM; Voss JE; Gunn BM; McLellan JS; Baric RS; Gralinski LE; Walker LM
    Science; 2021 Feb; 371(6531):823-829. PubMed ID: 33495307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
    Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
    J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice.
    Martinez DR; Schäfer A; Gobeil S; Li D; De la Cruz G; Parks R; Lu X; Barr M; Stalls V; Janowska K; Beaudoin E; Manne K; Mansouri K; Edwards RJ; Cronin K; Yount B; Anasti K; Montgomery SA; Tang J; Golding H; Shen S; Zhou T; Kwong PD; Graham BS; Mascola JR; Montefiori DC; Alam SM; Sempowski G; Sempowski GD; Khurana S; Wiehe K; Saunders KO; Acharya P; Haynes BF; Baric RS
    Sci Transl Med; 2022 Jan; 14(629):eabj7125. PubMed ID: 34726473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
    J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice.
    Martinez DR; Schaefer A; Gobeil S; Li D; De la Cruz G; Parks R; Lu X; Barr M; Manne K; Mansouri K; Edwards RJ; Yount B; Anasti K; Montgomery SA; Shen S; Zhou T; Kwong PD; Graham BS; Mascola JR; Montefiori DC; Alam M; Sempowski GD; Wiehe K; Saunders KO; Acharya P; Haynes BF; Baric RS
    bioRxiv; 2021 Apr; ():. PubMed ID: 33948590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses.
    Wang Y; Liu M; Shen Y; Ma Y; Li X; Zhang Y; Liu M; Yang XL; Chen J; Yan R; Luan D; Wang Y; Chen Y; Wang Q; Lin H; Li Y; Wu K; Zhu T; Zhao J; Lu H; Wen Y; Jiang S; Wu F; Zhou Q; Shi ZL; Huang J
    Cell Discov; 2022 Apr; 8(1):36. PubMed ID: 35443747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
    J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
    Wang P; Casner RG; Nair MS; Yu J; Guo Y; Wang M; Chan JF; Cerutti G; Iketani S; Liu L; Sheng Z; Chen Z; Yuen KY; Kwong PD; Huang Y; Shapiro L; Ho DD
    Emerg Microbes Infect; 2022 Dec; 11(1):147-157. PubMed ID: 34836485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses.
    Wang P; Casner RG; Nair MS; Yu J; Guo Y; Wang M; Chan JF; Cerutti G; Iketani S; Liu L; Sheng Z; Chen Z; Yuen KY; Kwong PD; Huang Y; Shapiro L; Ho DD
    bioRxiv; 2021 Oct; ():. PubMed ID: 34671769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies.
    Jette CA; Cohen AA; Gnanapragasam PNP; Muecksch F; Lee YE; Huey-Tubman KE; Schmidt F; Hatziioannou T; Bieniasz PD; Nussenzweig MC; West AP; Keeffe JR; Bjorkman PJ; Barnes CO
    Cell Rep; 2021 Sep; 36(13):109760. PubMed ID: 34534459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.
    Tortorici MA; Czudnochowski N; Starr TN; Marzi R; Walls AC; Zatta F; Bowen JE; Jaconi S; di Iulio J; Wang Z; De Marco A; Zepeda SK; Pinto D; Liu Z; Beltramello M; Bartha I; Housley MP; Lempp FA; Rosen LE; Dellota E; Kaiser H; Montiel-Ruiz M; Zhou J; Addetia A; Guarino B; Culap K; Sprugasci N; Saliba C; Vetti E; Giacchetto-Sasselli I; Silacci Fregni C; Abdelnabi R; Caroline Foo SY; Havenar-Daughton C; Schmid MA; Benigni F; Cameroni E; Neyts J; Telenti A; Snell G; Virgin HW; Whelan SPJ; Bloom JD; Corti D; Veesler D; Pizzuto MS
    bioRxiv; 2021 Apr; ():. PubMed ID: 33851169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.
    Sui J; Deming M; Rockx B; Liddington RC; Zhu QK; Baric RS; Marasco WA
    J Virol; 2014 Dec; 88(23):13769-80. PubMed ID: 25231316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad sarbecovirus neutralization by a human monoclonal antibody.
    Tortorici MA; Czudnochowski N; Starr TN; Marzi R; Walls AC; Zatta F; Bowen JE; Jaconi S; Di Iulio J; Wang Z; De Marco A; Zepeda SK; Pinto D; Liu Z; Beltramello M; Bartha I; Housley MP; Lempp FA; Rosen LE; Dellota E; Kaiser H; Montiel-Ruiz M; Zhou J; Addetia A; Guarino B; Culap K; Sprugasci N; Saliba C; Vetti E; Giacchetto-Sasselli I; Fregni CS; Abdelnabi R; Foo SC; Havenar-Daughton C; Schmid MA; Benigni F; Cameroni E; Neyts J; Telenti A; Virgin HW; Whelan SPJ; Snell G; Bloom JD; Corti D; Veesler D; Pizzuto MS
    Nature; 2021 Sep; 597(7874):103-108. PubMed ID: 34280951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif.
    Hauser BM; Sangesland M; Lam EC; Denis KJS; Feldman J; Yousif AS; Caradonna TM; Kannegieter T; Balazs AB; Lingwood D; Schmidt AG
    bioRxiv; 2021 Jun; ():. PubMed ID: 33330872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
    Starr TN; Czudnochowski N; Liu Z; Zatta F; Park YJ; Addetia A; Pinto D; Beltramello M; Hernandez P; Greaney AJ; Marzi R; Glass WG; Zhang I; Dingens AS; Bowen JE; Tortorici MA; Walls AC; Wojcechowskyj JA; De Marco A; Rosen LE; Zhou J; Montiel-Ruiz M; Kaiser H; Dillen JR; Tucker H; Bassi J; Silacci-Fregni C; Housley MP; di Iulio J; Lombardo G; Agostini M; Sprugasci N; Culap K; Jaconi S; Meury M; Dellota E; Abdelnabi R; Foo SC; Cameroni E; Stumpf S; Croll TI; Nix JC; Havenar-Daughton C; Piccoli L; Benigni F; Neyts J; Telenti A; Lempp FA; Pizzuto MS; Chodera JD; Hebner CM; Virgin HW; Whelan SPJ; Veesler D; Corti D; Bloom JD; Snell G
    Nature; 2021 Sep; 597(7874):97-102. PubMed ID: 34261126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.
    Liu L; Iketani S; Guo Y; Reddem ER; Casner RG; Nair MS; Yu J; Chan JF; Wang M; Cerutti G; Li Z; Morano NC; Castagna CD; Corredor L; Chu H; Yuan S; Poon VK; Chan CC; Chen Z; Luo Y; Cunningham M; Chavez A; Yin MT; Perlin DS; Tsuji M; Yuen KY; Kwong PD; Sheng Z; Huang Y; Shapiro L; Ho DD
    Sci Transl Med; 2022 May; 14(646):eabn6859. PubMed ID: 35438546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2.
    Feng Y; Yuan M; Powers JM; Hu M; Munt JE; Arunachalam PS; Leist SR; Bellusci L; Adams LE; Sundaramurthy S; Shirreff LM; Mallory ML; Scooby TD; Moreno A; O'Hagan DT; Kleanthous H; Villinger FJ; Veesler D; King NP; Suthar MS; Khurana S; Baric RS; Wilson IA; Pulendran B
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice.
    Martinez DR; Schafer A; Gavitt TD; Mallory ML; Lee E; Catanzaro NJ; Chen H; Gully K; Scobey T; Korategere P; Brown A; Smith L; Parks R; Barr M; Newman A; Bowman C; Powers JM; Mansouri K; Edwards RJ; Baric RS; Haynes BF; Saunders KO
    bioRxiv; 2023 May; ():. PubMed ID: 37293083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice.
    Martinez DR; Schäfer A; Gavitt TD; Mallory ML; Lee E; Catanzaro NJ; Chen H; Gully K; Scobey T; Korategere P; Brown A; Smith L; Parks R; Barr M; Newman A; Bowman C; Powers JM; Soderblom EJ; Mansouri K; Edwards RJ; Baric RS; Haynes BF; Saunders KO
    Cell Rep; 2023 Oct; 42(10):113248. PubMed ID: 37858337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.